{
  "trial_id": "NCT04701034",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Women with \u2265 2 consecutive pregnancy losses (miscarriages or biochemical pregnancies)",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "\u2264 completed gestational week 10 after ART with the present partner or with an egg/semen donor",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "BMI \u226535",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Age \u226541",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Significant uterine malformation(s)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known parental balanced chromosomal translocations",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "\u22652 previous pregnancies with fetuses with known abnormal karyotype",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with IgA deficiency, IgA-autoantibodies or hyperprolinaemia",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Treatment with medication interacting with prednisolone",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "CYP3A4-inhibitors (fx erythromycin, itraconazole, ritonavir, lopinavir)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "CYP3A4-inductors (fx phenobarbital, phenytoin og rifampicin), loop diuretics, thiazides, amphotericin B, beta2-agonists, antidiabetics, interleukin-2, somatotropins, anticholinergics and regular treatment with NSAIDs.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients with moderate/severe hypertension, diabetes mellitus, heart insufficiency, severe mental disorders, Cushing syndrome, myasthenia gravis, ocular herpes simplex, pheochromocytoma, systemic sclerosis, and moderate/severe renal dysfunction.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients with a clinical or biochemical profile indicating need for heparin or levothyroxine treatment during pregnancy",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Previous treatment with IVIg",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Allergy to prednisolone and/or IVIg",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "AMH <4 pmol/L. If transfer of donor egg is planned for her IVF cycle, the AMH value",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient presents with a severe 'exploding' headache following a head injury. She has been diagnosed with an arteriovenous malformation (AVM) and is being treated for spontaneous intraventricular hemorrhage.",
  "_meta": {
    "topic_id": "3",
    "trial_id": "NCT04701034",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}